New insights about <em>Candida auris</em>

10:45 AM • 1066 • Characterisation of the differential pathogenicity of <em>Candida auris</em> in a <em>Galleria mellonella</em> infection model > V. Victor GARCIA-BUSTOS (Valencia) 10:55 AM • 618 • Mannitol salt agar auris: a useful medium for differentiating <em>Candida auris</em> > T. Teresa NASCIMENTO (Lisbon) 11:15 AM • 381 • Use of remote video auditing (RVA) in prevention of nosocomial transmission of <em>Candida auris</em> > A. Akshay KHATRI (Manhasset, New York) 11:25 AM • 1928 • Antifungal activity of nitroxoline against <em>Candida auris </em>isolates > F. Frieder FUCHS (Cologne) 11:35 AM • 1937 • Outcomes of oral ibrexafungerp in the treatment of ten patients with <em>Candida auris </em>infections, from the CARES Study > N. Nkechi E AZIE (Jersey City) 11:45 AM • 662 • Clinical efficacy and safety of the novel antifungal fosmanogepix in patients with candidaemia and/or invasive candidiasis caused by <em>Candida auris</em>: results from a phase II proof of concept trial > B. Bart Jan KULLBERG (Nijmegen) 11:55 AM • INT84 • Q&A/Discussion